Global Cord Blood Corp (CO.N)
CO.N on New York Stock Exchange
9.69USD
4:02pm EDT
9.69USD
4:02pm EDT
Change (% chg)
$-0.25 (-2.52%)
$-0.25 (-2.52%)
Prev Close
$9.94
$9.94
Open
$9.84
$9.84
Day's High
$9.88
$9.88
Day's Low
$9.65
$9.65
Volume
29,249
29,249
Avg. Vol
57,890
57,890
52-wk High
$14.95
$14.95
52-wk Low
$8.55
$8.55
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec | 244.99 | 0.610 |
| Sep | 234.57 | 0.600 | |
| Jun | 224.22 | 0.620 | |
| FY 2017 | Mar '17 | 202.00 | 0.383 |
| Dec | 200.89 | 0.765 | |
| Sep | 184.14 | 0.228 | |
| Jun | 172.95 | 0.215 | |
| FY 2016 | Mar '16 | 156.78 | 0.113 |
| Dec | 169.37 | 0.691 | |
| Sep | 171.48 | 0.256 | |
| Jun | 165.36 | 0.186 |
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 1 | 42.83 | 42.83 | 42.83 | -- |
| Quarter Ending Dec-18 | 1 | 44.52 | 44.52 | 44.52 | -- |
| Year Ending Mar-18 | 1 | 149.92 | 149.92 | 149.92 | -- |
| Year Ending Mar-19 | 1 | 174.84 | 174.84 | 174.84 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 1 | 0.12 | 0.12 | 0.12 | -- |
| Quarter Ending Dec-18 | 1 | 0.13 | 0.13 | 0.13 | -- |
| Year Ending Mar-18 | 1 | 0.39 | 0.39 | 0.39 | -- |
| Year Ending Mar-19 | 1 | 0.50 | 0.50 | 0.50 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 28.92 | 29.90 | 34.14 | |
| P/E High - Last 5 Yrs. | 31.41 | 122.19 | 47.66 | |
| P/E Low - Last 5 Yrs. | 11.58 | 25.95 | 25.16 | |
| Beta | 0.95 | 0.49 | 0.78 | |
| Price to Sales (TTM) | 8.32 | 10.79 | 8.57 | |
| Price to Book (MRQ) | 2.38 | 4.33 | 4.34 | |
| Price to Tangible Book (MRQ) | 2.55 | 5.92 | 6.03 | |
| Price to Cash Flow (TTM) | -- | 18.93 | 22.77 | |
| % Owned Institutions | 19.83 | 4.85 | 2.40 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.94 | 1.68 | |
| Dividend Yield - 5 Year Avg | -- | 0.77 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 6.34 | -6.55 | |
| Payout Ratio(TTM) | 0.00 | 25.37 | 39.30 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 21.96 | 9.73 | 5.00 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 26.73 | 9.24 | 12.49 | |
| Sales - 5 Yr. Growth Rate | 14.84 | 13.91 | 7.91 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -20.31 | 16.33 | 40.62 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 67.40 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -2.28 | 7.44 | 8.03 | |
| Capital Spending - 5 Yr. Growth Rate | -27.50 | 10.84 | 7.42 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 9.20 | 4.81 | 2.56 |
| Current Ratio (MRQ) | 9.27 | 5.03 | 3.64 |
| LT Debt to Equity (MRQ) | -- | 44.67 | 12.92 |
| Total Debt to Equity (MRQ) | 0.00 | 52.71 | 17.37 |
| Interest Coverage (TTM) | 2.49 | 30.32 | 35.98 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 80.32 | 42.33 | 54.96 | |
| Gross Margin - 5 Yr. Avg. | 80.02 | 44.51 | 52.86 | |
| EBITD Margin (TTM) | 32.46 | -- | -- | |
| EBITD - 5 Yr. Avg | 42.97 | 9.18 | 15.70 | |
| Operating Margin (TTM) | 32.46 | 6.97 | -0.77 | |
| Operating Margin - 5 Yr. Avg. | 35.52 | 1.59 | 10.94 | |
| Pre-Tax Margin (TTM) | 32.01 | 9.20 | 1.31 | |
| Pre-Tax Margin - 5 Yr. Avg. | 25.72 | 5.54 | 11.12 | |
| Net Profit Margin (TTM) | 27.38 | 6.35 | -1.98 | |
| Net Profit Margin - 5 Yr. Avg. | 18.37 | 2.92 | 7.48 | |
| Effective Tax Rate (TTM) | 14.48 | 510.95 | 29.95 | |
| Effective Tax Rate - 5 Yr. Avg. | 28.56 | 30.38 | 24.12 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 132,857 | 3,087,209 | 736,570,410 | |
| Net Income/Employee (TTM) | 36,373 | 73,393 | 85,786,139 | |
| Receivable Turnover (TTM) | 6.71 | 8.85 | 6.05 | |
| Inventory Turnover (TTM) | 5.61 | 56.22 | 3.65 | |
| Asset Turnover (TTM) | 0.17 | 0.59 | 0.88 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 4.62 | 6.27 | 10.37 | |
| Return on Assets - 5 Yr. Avg. | 3.07 | 6.53 | 11.08 | |
| Return on Investment (TTM) | 5.62 | 7.75 | 13.17 | |
| Return on Investment - 5 Yr. Avg. | 3.52 | 8.23 | 14.39 | |
| Return on Equity (TTM) | 9.73 | 11.08 | 15.14 | |
| Return on Equity - 5 Yr. Avg. | 7.20 | 12.05 | 15.73 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 14.63 | 9.88 | 14.84 |
| EPS (TTM) % | 27.70 | -0.19 | -2.28 |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Global Cord Blood Corp
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 5.30 | 3.75 | 99 | 33 |
| 13 Week | -11.41 | -13.35 | 49 | 51 |
| 26 Week | -1.19 | -4.17 | 99 | 59 |
| 52 Week | 8.87 | -4.50 | 99 | 39 |
| YTD | -0.10 | -3.71 | 99 | 53 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Nanjing Xinjiekou Department Store Clarifies Media Reports On Investment In Unit China Cord Blood
- BRIEF-China Cord Blood Says Shareholders Approved Co's Name Change
- BRIEF-China Cord Blood Q3 Revenue RMB 245 Million
- BRIEF-China Cord Blood Corp To Change Corporate Name To "Global Cord Blood Corp"
- BRIEF-Nanjing Ying Peng Becomes Major Shareholder Of China Cord Blood Corp
Institutional Holders
| % Shares Owned: | 19.77% |
| # of Holders: | 67 |
| Total Shares Held: | 23,845,401 |
| 3 Mo. Net Change: | -2,646,981 |
| # New Positions: | 16 |
| # Closed Positions: | 10 |
| # Increased Positions: | 31 |
| # Reduced Positions: | 29 |
| # Net Buyers: | 2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.